Market/ 3D Printing health care
Comments: Marketsegments are ..
A new report by visiongain forecasts the world market for 3D printing in the healthcare industry will be worth $4043m in 2018. That medical market generated
$1,264m in 2013, according to 3D Printing for Healthcare: R&D,
Industry and Market 2014-2024, published in January 2014. Visiongain is a
business information provider based in London, UK.
Visiongain forecasts the overall market for 3D printing (additive
manufacturing) in the healthcare industry will expand rapidly from 2014.
That multidimensional printing offers advantages over traditional
manufacturing methods as it facilitates the production of highly
specific complex geometries and surfaces. It is suited to the production
of high value, low volume products. As a result, those printers give
methods of synthesis suited to manufacturing products for the healthcare
industry, where the demand for high quality, patient specific products
is increasing, particularly in orthopaedics.
Jennifer Taylor, a pharmaceutical industry analyst in visiongain,
said: “As 3D printing technology has developed and become more
widespread, it has been used for an increasing number of applications in
the healthcare industry. It is now an established manufacturing method
in the formation of prototypes, medical models and dental products. More
recently, the technology has been employed in the production of
patient-specific orthopaedic and cranio-maxillofacial implants, a number
of which have already received regulatory approval in the US and EU.
More are under review. These implants apparently not only perform
better, but their use results in cost savings derived from reduced
surgery times. Companies in the field are beginning to enter into
collaboration agreements with the industry-leading orthopaedic device
manufacturers, which will drive market penetration of these 3D printed
implants. It is expansion in this application that will be the main
driver of growth during our forecast period 2014-2024.
“Technological advances in this dynamic industry are ever ongoing and
applications of additive manufacturing in healthcare are expanding. An
area of particular activity is that of bioprinting; there are a number
of research groups and start-up companies working in this field.
Bioprinted tissue will become commercially available for both drug
development and therapeutic purposes during our forecast period, and
will become an important subsector of the 3D printed products industry.”
Visiongain’s new report shows revenue forecasts to 2024 at world
market and submarket level. It forecasts the world-level submarkets of
3D printing technology and that of printed products for medicine. The
data gives a breakdown of the 3D printed products market into the
following subsectors:
Reprint Forbes, 22/08/13
